Instagram Ern-EyeFacebook Ern-EyeTwitter Ern-EyeLinkedIn Ern-EyeYouTube Ern-EyeHow to use the speech recognition tool?
VITAL
VITAL
Prospective study of visual function in USHER syndrome induced by MYO7A mutation and retinotosis pigmentosa.
Type: Observational
Status of the trial: Unknown
Orphan Drug Recognition: NA
Inclusion
- Opening Date: 2017-11-03
- Closing Date: 2019-11-04
Criteria
Inclusion: USH1B group: genotype with two pathogenic mutations of the MYO7A gene RP group: a genotype with a pathogenic mutation identified. For all: Diagnosis of confirmed retinopathy pigmentosa
Exclusion: Persons who have previously participated in a clinical trial of gene therapy or with ocular disease or ocular opacity. History of amblyopia
Children: Yes
Adults: Yes
Funder Type: industry, public
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Workgroups
Retinal Rare Eye Diseases (WG1)
This ERN is supported by:
